Investments and investor services
Hemogenyx teams up with Johnson & Johnson to develop new lupus treatment
Hemogenyx is to build a humanised mouse model of the lupus disease, which scientists will then use to help develop a new treatment
Company
Hemogenyx Pharmaceuticals PLC
LON:HEMO
Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
128 stories · page 5 of 7
Investments and investor services
FTSE 100 closes positively as PM Theresa May says gov't is working towards a good Brexit deal
Britain's blue-chip benchmark finished up around 31 points at 7,029
HemoGenyx optimistic on CDX antibodies prospects
HemoGenyx said it was pleased with the opportunities that had been unlocked for its CDX antibodies during the first half
Well-received interim results boost Biome Technologies and Gamma Communications
A look at some of the biggest risers and fallers in London on Monday
Archive
Proactive news snapshot: Hurricane Energy, SkinBioTherapeutics, Tissue Regenix …
A glance at some of the day's highlights from the Proactive Investors newswire
FTSE 100 sails higher, bolstered by stumbling sterling
The UK blue-chip index finished up over 72 points at 7,504, while the mid-cap FTSE 250 was also higher
Archive
Proactive news snapshot: Papua Mining, Midatech Pharma, Sound Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Redcentric shares slip as it downgrades outlook for 2019
A look at some of the biggest risers and fallers in London on Friday
FTSE 100 closes lower on day and week after lacklustre trading; miners weigh
Footsie closed out down around 23 points at 7,681 and was also down on the week as a whole, off around 0.26%
Archive
Proactive news snapshot: HemoGenyx Pharmaceuticals, Harvest Minerals, Touchstone Exploration …
A glance at some of the day's highlights from the Proactive Investors newswire
MTI Wireless shares fall as it reports decrease in revenues and profit
A look at some of the top risers and fallers in London on Monday
Investments and investor services
Hemogenyx teams up with global pharma company to help further develop CDX antibodies
Hemogenyx will now have access to free technical support and advanced methods of engineering which should aid development of its flagship CDX antibodies
FTSE 100 closes in red as there is little around to spark investor interest
FTSE 250 fared better though closing ahead by around 15 points at 20,800.
Archive
Proactive news snapshot: Challenger Acquisitions, SDX Energy, Greencoat UK Wind …
A glance at some of the day's highlights from the Proactive Investors newswire
Nanoco Group on the front foot after receiving £1.8mln payment from US partner
A look at some of the top risers and fallers in London on Tuesday
Investments and investor services
HemoGenyx signs collaboration agreement with Rockefeller University to develop new Lupus treatments
Vladislav Sandler, CEO and co-founder of HemoGenyx, said: “This agreement with Rockefeller has the potential to extend our product candidate opportunities into a new and exciting area, and we would fully expect to see the work funded throug
FTSE 100 closes slightly in red; Shire biggest gainer
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
Proactive news snapshot: OptiBiotix Health, Kromek Group, Union Jack Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Cora Gold leads small cap risers as it boasts “exciting high grade results”
A look at some of the biggest risers and fallers in London on Tuesday.